HEAD AND NECK CANCERS- SQUAMOUS CELL
Clinical trials for HEAD AND NECK CANCERS- SQUAMOUS CELL explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CANCERS- SQUAMOUS CELL trials appear
Sign up with your email to follow new studies for HEAD AND NECK CANCERS- SQUAMOUS CELL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection fights head and neck cancer from the inside
Disease control Recruiting nowThis early-stage trial tests a new treatment called VLPONC-01, which is injected directly into head and neck tumors. It delivers a substance (IL-12) that may help the immune system attack the cancer. Some participants will also receive the immunotherapy drug pembrolizumab. The ma…
Matched conditions: HEAD AND NECK CANCERS- SQUAMOUS CELL
Phase: PHASE1 • Sponsor: VLP Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Blood test may predict head and neck cancer progression
Knowledge-focused Recruiting nowThis observational study is testing a new blood test that uses a microfluidic chip to detect cancer cells and immune cells in 30 patients with recurrent or metastatic head and neck cancer. The goal is to see if these blood markers can predict how long patients live without their …
Matched conditions: HEAD AND NECK CANCERS- SQUAMOUS CELL
Sponsor: National Taiwan University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC